Doximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk

Dow Jones

2025/05/16

1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com)

(END) Dow Jones Newswires

May 16, 2025 11:08 ET (15:08 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2535698314"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2535698314\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2535698314?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-16 23:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2535698314","market":"nz","top_or_hot":-1,"title":"Doximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 16, 2025 11:08 ET (15:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Doximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoximity's Stellar FY25 Will Be Tough Act to Follow -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-16 23:08</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 16, 2025 11:08 ET (15:08 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4613","symbol_name":"AI应用软件","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2535698314","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2535698314","pubTimestamp":1747408080,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4613":"AI应用软件","BK4585":"ETF&股票定投概念","BK4588":"碎股","DOCS":"Doximity, Inc.","BK4167":"医疗保健技术","BK4551":"寇图资本持仓","BK4539":"次新股"},"translate_title":"Doximity在2025财年的出色表现将是一项艰难的行动——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DOCS":1},"content_text":"1108 ET - Doximity's fiscal 2025, which ended March 31, was a strong growth year that fiscal 2026 will have a tough time topping, Mizuho analysts say in a research note. Sales rose 20% from strong revenue retention, particularly among Doximity's top 20 customers. The provider of a networking platform for healthcare professionals now has 116 customers contributing more than $500 million in annual subscription revenue, and those customers account for 84% of FY25's revenue, lowering the risk of small-customer churn, the analysts say. Doximity also grew revenue by 2 to 3 percentage points by shifting to more multi-module integrated offerings, they say. That tough comparison with FY25, along with rising macro uncertainty, explains why Doximity is only guiding for half as much revenue growth in FY26, the analysts say. (dean.seal@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 16, 2025 11:08 ET (15:08 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}